A Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis

NCT02977533 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Progressive Multiple Sclerosis

Interventions

DRUG: GZ402668
DRUG: Placebo
DRUG: Acyclovir

Sponsor

Sanofi